Limits...
A randomised controlled trial of PEGASUS, a psychoeducational programme for young people with high-functioning autism spectrum disorder.

Gordon K, Murin M, Baykaner O, Roughan L, Livermore-Hardy V, Skuse D, Mandy W - J Child Psychol Psychiatry (2014)

Bottom Line: After PEGASUS, participants had more general knowledge about ASD, and showed a greater awareness of their collection of unique strengths and difficulties associated with ASD.Psychoeducation did not lower self-esteem.This RCT provides initial evidence for PEGASUS's efficacy as a psychoeducation programme for people with ASD.

View Article: PubMed Central - PubMed

Affiliation: Oxford Health NHS Foundation Trust, Aylesbury, Buckinghamshire, UK.

Show MeSH

Related in: MedlinePlus

Flow of participants through the trial
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4402033&req=5

fig01: Flow of participants through the trial

Mentions: Figure 1 describes the flow of participants through the study. Sixty-seven families contacted the study for information, but did not progress to receiving a home visit. Of these, 41 decided not to participate after being given information about the study, and a further 26 were found not to meet inclusion criteria during the telephone screen. Of the 17 children who passed the telephone screen, but who subsequently failed to meet full inclusion criteria, eight scored below 65 on the IQ test and seven were deemed unsuitable for group work due to challenging behaviour and/or hyperactivity. For two children, it emerged that, in contrast to their parents, they had negative attitudes to participating in the study, hence they were excluded for ethical reasons, as it was not considered possible to attain true assent from them, independent of parental pressure. Another child withdrew shortly after his home visit, having met inclusion criteria, due to a change in family circumstances. Forty-eight children took part in this RCT, after passing inclusion criteria and being randomly assigned to either the control or PEGASUS condition.


A randomised controlled trial of PEGASUS, a psychoeducational programme for young people with high-functioning autism spectrum disorder.

Gordon K, Murin M, Baykaner O, Roughan L, Livermore-Hardy V, Skuse D, Mandy W - J Child Psychol Psychiatry (2014)

Flow of participants through the trial
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4402033&req=5

fig01: Flow of participants through the trial
Mentions: Figure 1 describes the flow of participants through the study. Sixty-seven families contacted the study for information, but did not progress to receiving a home visit. Of these, 41 decided not to participate after being given information about the study, and a further 26 were found not to meet inclusion criteria during the telephone screen. Of the 17 children who passed the telephone screen, but who subsequently failed to meet full inclusion criteria, eight scored below 65 on the IQ test and seven were deemed unsuitable for group work due to challenging behaviour and/or hyperactivity. For two children, it emerged that, in contrast to their parents, they had negative attitudes to participating in the study, hence they were excluded for ethical reasons, as it was not considered possible to attain true assent from them, independent of parental pressure. Another child withdrew shortly after his home visit, having met inclusion criteria, due to a change in family circumstances. Forty-eight children took part in this RCT, after passing inclusion criteria and being randomly assigned to either the control or PEGASUS condition.

Bottom Line: After PEGASUS, participants had more general knowledge about ASD, and showed a greater awareness of their collection of unique strengths and difficulties associated with ASD.Psychoeducation did not lower self-esteem.This RCT provides initial evidence for PEGASUS's efficacy as a psychoeducation programme for people with ASD.

View Article: PubMed Central - PubMed

Affiliation: Oxford Health NHS Foundation Trust, Aylesbury, Buckinghamshire, UK.

Show MeSH
Related in: MedlinePlus